Pharmaceutical contract services round-up
In a round-up of motley pharmaceutical services contracts, Outsourcing-Pharma takes a look at deals recently inked by Yoh, PDI, and PRA International.
Archives for April 10, 2007
DOR's oral leuprolide to start trials mid-year
US company DOR BioPharma plans to start clinical trials in the next few months with what could be the first oral formulation of the widely used prostate cancer treatment leuprolide.
Abbott's new biotech plant on the 'Bio Island' good to go
US pharma Abbott has announced the opening of its new state-of the-art biologics manufacturing plant in Puerto Rico.
Pharmatek opens new plant; Pace buys P3
Pharmatek has moved to a new larger lab and manufacturing facility while Pace Analytical Life Sciences recently acquired lab testing firm P3 Scientific.
Octagon to address process problems in clinical R&D
Octagon has bought an electronic data capture (EDC) company and is now claiming to be the first company to address the process problem in clinical R&D by offering "an end-to-end solution that crosses traditional functional boundaries."
Caterpillar cells to churn out flu vaccine
An experimental flu vaccine produced in insect cells could be a potential money-saver for pharma firms, and has proved just as effective as vaccines produced using conventional egg-based techniques.